In vitro and in vivo study on the antioxidant activity of dexrazoxane-Reference-Cited by-同舟云学术

In vitro and in vivo study on the antioxidant activity of dexrazoxane

Published:2010-04 Issue:4 Volume:64 Page:259-263
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Galetta Fabio,Franzoni Ferdinando,Cervetti Giulia,Regoli Francesco,Fallahi Poupak,Tocchini Leonardo,Carpi Angelo,Antonelli Alessandro,Petrini Mario,Santoro Gino

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference31 articles.

1. Cardiotoxicity of adriamycin and related anthracyclines;Lenaz;Cancer Treat Rev,1976

2. A clinicopathologic analysis of doxorubicin cardiotoxicity;Lefrak;Cancer,1973

3. Epidemiology of anthracycline cardiotoxicity in children and adults;Grenier;Semin Oncol,1998

4. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia;Lipshultz;J Clin Oncol,2005

5. Doxorubicin cardiotoxicity: analysis of prevailing hypothesis;Olson;FASEB J,1990

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology;International Journal of Molecular Sciences;2022-09-13

2. Antioxidant Therapy in Parkinson’s Disease: Insights from Drosophila melanogaster;Antioxidants;2020-01-07

3. Cardioprotective Effect of Phase 3 Clinical Anticancer Agent, RRx-001, in Doxorubicin-Induced Acute Cardiotoxicity in Mice;Molecular Pharmaceutics;2019-04-30

4. Extravasation accidents with liposomal/liposomal pegylated anthracyclines treated with dexrazoxane;Anti-Cancer Drugs;2018-10

5. Modulatory Effects of Dexrazoxane Against Genotoxicity and Lipid Peroxidation Induced by Idarubicin in HepG2 Cells;International Journal of Cancer Management;2018-01-14